RSCIRedwood Scientific Technologies, Inc.

About Redwood Scientific Technologies, Inc. (RSCI)

Redwood Scientific Technologies, Inc. (RSCI) is a Drug Manufacturers - Specialty & Generic company headquartered in Albany, NY, United States whose shares trade over-the-counter on the Pink tier.

Redwood Scientific Technologies (RSCI) is a pharmaceutical company that develops, operates, and markets innovative over-the-counter products in a sublingual oral thin film strip. RSCI has begun clinical trials on two new products that will be marketed to help stop the addiction to nicotine. Redwood will bring back its product TBX-FREE for the addiction to nicotine in cigarettes. Redwood will also begin a trial on a product to stop the addiction to nicotine in vape delivery. Redwood Scientific is targeting the clinical trials that will conclude in 2024.

Products and services

Redwood Scientific Technologies (RSCI) develops, operates, and markets innovative over-the-counter FDA-registered drugs in a sublingual oral thin film strip. RSCI has begun clinical trials on two new products that will be marketed to help stop the addiction to nicotine. Redwood will bring back its product TBX-FREE for the addiction to nicotine in cigarettes.

RSCI key facts

Ticker symbol

RSCI

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Albany, NY, United States

Country of incorporation

US

Year of incorporation

1986

Employees

3

Estimated market cap

$26.64M (as of Apr 16, 2025)

Shares outstanding

204,943,802

Reporting standard

Alternative Reporting Standard

Audit status

Audited

Fiscal year end

12/31

Latest filing

Quarterly Report (Mar 31, 2024)

Redwood Scientific Technologies, Inc. leadership

• Jason Edward Thomas Cardiff — CEO
• Joseph Steven Budd — COO
• John Harrington — CFO

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with R